Table 1 Kaplan-Meier survival analysis for overall (OS) with respect to clinical parameters (n): number of patients
From: Expression of TRF2 and its prognostic relevance in advanced stage cervical cancer patients
Mean survival (months) | (95% CI) (months) | OS 5 years (%) | P-value | |
|---|---|---|---|---|
Stage (n) | ||||
IIB (7) | 85.3 | 73.9-96.8 | 85.7 | 0.02* |
IIB-IVA(13) | 53.7 | 32.7-70.1 | 38.5 | |
Age | ||||
>56 years | 71.3 | 56.3-86.4 | 60 | 0.28 |
<56 years | 57.8 | 37.1-78.4 | 50 | |
Apoptosis (n) | 0.18 | |||
High (9) | 70.7 | 52.7-88.6 | 63.6 | |
Low (11) | 57.4 | 39.1-75.7 | 44.4 | |
Grade (n) | 0.06 | |||
High grade (11) | 53.6 | 36.6-70.6 | 33.3 | |
Low and medium grade (9) | 81.0 | 66.5-95.4 | 87.5 |